Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

BUY
$6.07 - $9.89 $3,368 - $5,488
555 Added 1.85%
30,555 $222,000
Q2 2020

Aug 13, 2020

BUY
$6.18 - $10.76 $30,900 - $53,800
5,000 Added 20.0%
30,000 $225,000
Q1 2020

May 15, 2020

BUY
$6.03 - $15.24 $60,300 - $152,400
10,000 Added 66.67%
25,000 $157,000
Q2 2019

Aug 14, 2019

BUY
$13.4 - $17.67 $201,000 - $265,050
15,000 New
15,000 $221,000

Others Institutions Holding MGTA

About Magenta Therapeutics, Inc.


  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.